Effect of prostate biopsy hemorrhage on MRDW and MRS imaging

Korean Journal of Urology

Volumn 52, Issue 10, 2011, Pages 674-680

  Lee, Jong Yeon ^a   Chang, In Ho ^a   Moon, Young Tae ^a   Kim, Kyung Do ^a   Myung, Soon Chul ^a   Kim, Tae Hyoung ^a   Lee, Jong Beum ^a  

^a Chung Ang University College of Medicine   (South Korea)

Author keywords

Hemorrhage; Magnetic resonance imaging; Magnetic resonance spectro scopy; Prostatic neoplasms

Indexed keywords

CHOLINE; CITRIC ACID; CREATININE;

ADULT; AGED; ARTICLE; BLEEDING; CANCER DIAGNOSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE BIOPSY; PROSTATE CANCER;

EID: 80655129276     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2011.52.10.674     Document Type: Article

References (33)

1. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C. Leveling of prostate cancer mortality in Western Europe. Prostate 2004;60: 46-52.
2. Bangma CH, Kranse R, Blijenberg BG, Schröder FH. The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 men. Urology 1995; 46:773-8.
3. Pepe P, Panella P, D'Arrigo L, Savoca F, Pennisi M, Aragona F. Should men with serum prostate-specific antigen < or =4 ng/ml and normal digital rectal examination undergo a prostate biopsy? A literature review. Oncology 2006;70:81-9.
4. Schiebler ML, Schnall MD, Pollack HM, Lenkinski RE, Tomaszewski JE, Wein AJ, et al. Current role of MR imaging in the staging of adenocarcinoma of the prostate. Radiology 1993; 189:339-52.
5. White S, Hricak H, Forstner R, Kurhanewicz J, Vigneron DB, Zaloudek CJ, et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 1995;195:385-90.
6. Westphalen AC, Coakley FV, Qayyum A, Swanson M, Simko JP, Lu Y, et al. Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging. Radiology 2008;246:177-84.
7. Bostwick DG, Graham SD Jr, Napalkov P, Abrahamsson PA, di Sant'agnese PA, Algaba F, et al. Staging of early prostate cancer: a proposed tumor volume-based prognostic index. Urology 1993;41:403-11.
8. Park SY, Kim JJ, Kim TH, Lim SH, Han DH, Park BK, et al. The role of endorectal magnetic resonance imaging in predicting ex-traprostatic extension and seminal vesicle invasion in clinically localized prostate cancer. Korean J Urol 2010;51:308-12.
9. Casciani E, Gualdi GF. Prostate cancer: value of magnetic resonance spectroscopy 3D chemical shift imaging. Abdom Imaging 2006;31:490-9.
10. Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Carroll P, Nelson SJ. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. Radiology 1996;198:795-805.
11. Yacoe ME, Sommer G, Peehl D. In vitro proton spectroscopy of normal and abnormal prostate. Magn Reson Med 1991;19:429-38.
12. Lee KC, Sud S, Meyer CR, Moffat BA, Chenevert TL, Rehemtulla A, et al. An imaging biomarker of early treatment response in prostate cancer that has metastasized to the bone. Cancer Res 2007;67:3524-8.
13. Tamada T, Sone T, Jo Y, Yamamoto A, Yamashita T, Egashira N, et al. Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. Radiology 2008;248:531-9.
14. Hong SK, Kim DS, Lee WK, Park H, Kim JK, Doo SH, et al. Significance of postbiopsy hemorrhage observed on preoperative magnetic resonance imaging in performing robot-assisted lapa-roscopic radical prostatectomy. World J Urol 2010;28:721-6.
15. Schiebler ML, Tomaszewski JE, Bezzi M, Pollack HM, Kressel HY, Cohen EK, et al. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopatho-logic findings. Radiology 1989;172:131-7.
16. Ikonen S, Karkkainen P, Kivisaari L, Salo JO, Taari K, Vehmas T, et al. Magnetic resonance imaging of prostatic cancer: does detection vary between high and low gleason score tumors? Prostate 2000;43:43-8.
17. Stokes SH, Real JD, Adams PW, Clements JC, Wuertzer S, Kan W. Transperineal ultrasound-guided radioactive seed implantation for organ-confined carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1997;37:337-41.
18. Amin Z, Lees WR, Bown SG. Technical note: interstitial laser pho-tocoagulation for the treatment of prostatic cancer. Br J Radiol 1993;66:1044-7.
19. Lee F, Bahn DK, McHugh TA, Onik GM, Lee FT. US-guided percutaneous cryoablation of prostate cancer. Radiology 1994; 192:769-76.
20. Chodak GW, Thisted RA, Gerber GS, Johansson JE, Adolfsson J, Jones GW, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med 1994;330:242-8.
21. Douketis JD. Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians. Thromb Res 2002;108:3-13.
22. Ikonen S, Kivisaari L, Vehmas T, Tervahartiala P, Salo JO, Taari K, et al. Optimal timing of post-biopsy MR imaging of the prostate. Acta Radiol 2001;42:70-3.
23. Qayyum A, Coakley FV, Lu Y, Olpin JD, Wu L, Yeh BM, et al. Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. AJR Am J Roentgenol 2004;183:1079-83.
24. Gibbs P, Pickles MD, Turnbull LW. Diffusion imaging of the prostate at 3.0 tesla. Invest Radiol 2006;41:185-8.
25. Pickles MD, Gibbs P, Sreenivas M, Turnbull LW. Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0T. J Magn Reson Imaging 2006;23:130-4.
26. Issa B. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging 2002;16:196-200.
27. Zelhof B, Pickles M, Liney G, Gibbs P, Rodrigues G, Kraus S, et al. Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer. BJU Int 2009;103:883-8.
28. Kozlowski P, Chang SD, Jones EC, Berean KW, Chen H, Goldenberg SL. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis--correlation with biopsy and histopathology. J Magn Reson Imaging 2006;24: 108-13.
29. Scheidler J, Hricak H, Vigneron DB, Yu KK, Sokolov DL, Huang LR, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. Radiology 1999;213:473-80.
30. Shimofusa R, Fujimoto H, Akamata H, Motoori K, Yamamoto S, Ueda T, et al. Diffusion-weighted imaging of prostate cancer. J Comput Assist Tomogr 2005;29:149-53.
31. Casciani E, Polettini E, Bertini L, Masselli G, Emiliozzi P, Amini M, et al. Contribution of the MR spectroscopic imaging in the diagnosis of prostate cancer in the peripheral zone. Abdom Imaging 2007;Epub ahead of print
32. Atlas SW, DuBois P, Singer MB, Lu D. Diffusion measurements in intracranial hematomas: implications for MR imaging of acute stroke. AJNR Am J Neuroradiol 2000;21:1190-4.
33. Maldjian JA, Listerud J, Moonis G, Siddiqi F. Computing diffusion rates in T2-dark hematomas and areas of low T2 signal. AJNR Am J Neuroradiol 2001;22:112-8.